
Senior Manager, Strategic Communications & PR
The Business of HLTH Podcast
District of Columbia, USA (Remote)
New York, USA (On-site)
Posted 6 months ago
Drive biotech corporate communications and patient advocacy for Nuvation Bio, shaping messaging, media relations, and stakeholder engagement at scale.
Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai.

The Business of HLTH Podcast
District of Columbia, USA (Remote)

Ross Stores, Inc.
New York City, NY (On-site)

The Business of HLTH Podcast
San Francisco, CA (Hybrid)

The Business of HLTH Podcast
Richmond, VA (Hybrid)

The Business of HLTH Podcast
Palo Alto, CA (Hybrid)